Patent Assignment Details
NOTE:Results display only for issued patents and published applications.
For pending or abandoned applications please consult USPTO staff.
|
Reel/Frame: | 061416/0163 | |
| Pages: | 3 |
| | Recorded: | 10/13/2022 | | |
Attorney Dkt #: | UTSL.P0093USD1/1001198278 |
Conveyance: | ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). |
|
Total properties:
2
|
|
Patent #:
|
NONE
|
Issue Dt:
|
|
Application #:
|
17829768
|
Filing Dt:
|
06/01/2022
|
Publication #:
|
|
Pub Dt:
|
09/15/2022
| | | | |
Title:
|
CANCER TREATMENT THROUGH RLIP76 PARTIAL DEPLETION
|
|
|
Patent #:
|
NONE
|
Issue Dt:
|
|
Application #:
|
17830027
|
Filing Dt:
|
06/01/2022
|
Publication #:
|
|
Pub Dt:
|
10/27/2022
| | | | |
Title:
|
REDUCING BLOOD GLUCOSE, INSULIN RESISTANCE, OR HYPERLIPIDEMIA THROUGH RLIP76 PARTIAL DEPLETION
|
|
Assignee
|
|
|
210 W. 7TH ST. |
AUSTIN, TEXAS 78701 |
|
Correspondence name and address
|
|
NORTON ROSE FULBRIGHT
|
|
98 SAN JACINTO BOULEVARD, SUITE 1100
|
|
AUSTIN, TX 78701-4255
|
Search Results as of:
05/29/2024 12:14 AM
If you have any comments or questions concerning the data displayed,
contact
PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified:
August 25, 2017 v.2.6
|